How to Get Rid of Fatty Liver

How to Get Rid of Fatty Liver: Evidence-Based Treatment Strategies That Work

If you’ve been diagnosed with non-alcoholic fatty liver disease (NAFLD), you’re likely wondering: Can fatty liver be reversed? The encouraging answer is yes—especially when caught early. NAFLD, which affects approximately 25-30% of adults globally and up to 70% of those with type 2 diabetes, is not a life sentence. With the right approach combining lifestyle modifications, dietary changes, and targeted interventions including gut health optimisation, many people can successfully reduce liver fat, reverse inflammation, and prevent progression to more serious stages of liver disease.

This comprehensive guide will walk you through evidence-based strategies for how to get rid of fatty liver, with a special emphasis on the often-overlooked but critically important gut-liver axis.

Understanding Fatty Liver Reversibility: What the Evidence Shows

Before diving into treatment strategies, it’s important to understand what “reversing” fatty liver means and what’s realistically achievable at different disease stages.

The Spectrum of Reversibility

Simple Steatosis (Fatty Liver): Highly reversible. Studies consistently show that lifestyle modifications can effectively eliminate fat accumulation in the liver when the disease hasn’t progressed beyond simple steatosis.

Non-Alcoholic Steatohepatitis (NASH): Weight reductions of 10% or more can induce near-universal NASH resolution and achieve some degree of fibrosis regression. Research demonstrates that NASH can be reversed in a significant proportion of patients who achieve substantial weight loss.

Fibrosis: Can be stabilised and, in some cases, reversed with significant weight loss and lifestyle modification. Studies show that weight loss and diet alteration lead to notable reductions in NAFLD activity scores, remission of steatohepatitis, and regression of fibrosis.

Cirrhosis: Advanced fibrosis and cirrhosis are more difficult to reverse but progression can be halted and complications can be managed with appropriate interventions.

The key message: The earlier you intervene, the better your outcomes. However, even advanced disease can be improved with comprehensive lifestyle changes.

Weight Loss: The Cornerstone of Fatty Liver Treatment

Currently, weight loss is the most effective treatment for NAFLD and is recommended in all national and international guidelines. The relationship between weight loss and liver improvement is dose-dependent—the more weight you lose, the greater the benefit to your liver.

How Much Weight Loss Do You Need?

Research has established clear thresholds for liver improvement:

3-5% weight loss: Reduces hepatic steatosis (fat in the liver)

7-10% weight loss: Improves inflammation and some fibrosis markers

≥10% weight loss: Achieves near-universal NASH resolution and significant fibrosis regression

Studies demonstrate that individuals who achieve weight loss of 10% or more show remarkable improvements. In one landmark study, a 1-year exercise intervention resulted in decreased waist circumference, intrahepatic triglyceride content, blood pressure, and hepatic fat accumulation in obese patients with NAFLD compared to control groups.

Importantly, weight loss benefits extend even to non-obese individuals with NAFLD. Research shows that NAFLD can be relieved in 67% of non-obese patients after structured exercise interventions, highlighting that improving metabolic health matters regardless of starting weight.

The Challenge: Achieving and Maintaining Weight Loss

While the benefits of weight loss are clear, sustained weight reduction remains challenging for many patients. This is why a comprehensive, multi-faceted approach is essential—one that doesn’t rely solely on willpower but addresses the underlying metabolic dysfunction, hormonal imbalances, and gut health issues that contribute to both weight gain and fatty liver disease.

The Mediterranean Diet: Your Liver’s Best Friend

At present, the best dietary treatment to improve NAFLD is adoption of a Mediterranean-style eating pattern. The European Association for the Study of the Liver specifically recommends the Mediterranean diet in their clinical practice guidelines for NAFLD management.

What Is the Mediterranean Diet?

The Mediterranean diet is characterised by:

• High intake of: Vegetables, fruits, legumes, nuts, whole grains, fish, and olive oil
• Moderate intake of: Poultry, eggs, and red wine (optional)
• Low intake of: Red meat, processed meats, sweets, and refined carbohydrates
• Emphasis on: Monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs)

Why the Mediterranean Diet Works for Fatty Liver

The Mediterranean diet influences NAFLD through multiple mechanisms:

1. Lipid Lowering Effects

The diet’s emphasis on healthy fats, particularly omega-3 PUFAs and MUFAs from olive oil, helps normalise blood lipid profiles. Studies show that omega-3 PUFA-rich diets reduce apoptosis, decrease fatty acid synthase content and activity, reduce inflammation, and improve glucose homeostasis, thereby decreasing NAFLD development.

Omega-3 PUFAs also correct glycemia levels, oxidative stress status, and metabolic endotoxemia. Research indicates that the risk of NAFLD is negatively associated with omega-3 PUFA intake, meaning patients with NAFLD and NASH typically consume fewer omega-3 PUFAs than healthy individuals.

2. Antioxidant Effects

The diet is rich in polyphenols and other antioxidants from fruits, vegetables, nuts, and olive oil. Individuals who adopt the Mediterranean diet show remarkable reductions in circulating oxidised LDL and inflammatory markers.

3. Anti-Inflammatory Properties

By minimising processed foods and emphasising whole, nutrient-dense options, the Mediterranean diet reduces systemic inflammation—a key driver of NAFLD progression to NASH.

4. Reduced Advanced Glycation End Products (AGEs)

Minimising intake of processed and high-fructose foods is a hallmark of the Mediterranean diet, which leads to decreased ingestion of AGEs. AGEs are associated with diabetes, are increased in patients with NASH, and are positively correlated with insulin resistance.

5. Fructose Limitation

The Mediterranean diet naturally limits fructose intake. Fructose promotes alterations in the gut microbiota, increases intestinal permeability, exacerbates lipid peroxidation and hepatic steatosis, and increases tumor necrosis factor-α (TNF-α) production.

Evidence Supporting the Mediterranean Diet for NAFLD

Studies demonstrate that the Mediterranean diet reduces the risk of type 2 diabetes, obesity, cancer, and cardiovascular diseases—all conditions closely related to NAFLD. The diet’s comprehensive benefits make it an ideal long-term eating pattern for liver health.

Exercise and Physical Activity: Moving Your Way to a Healthier Liver

Exercise notably decreases steatosis and reduces the risk of NAFLD progressing to NASH. Physical activity works through multiple mechanisms to improve liver health, and the benefits extend beyond those achieved through weight loss alone.

How Much Exercise Do You Need?

Research-backed recommendations include:

Aerobic Exercise: At least 150 minutes of moderate-intensity aerobic activity per week, or 75 minutes of vigorous-intensity activity

Resistance Training: 2-3 sessions per week targeting major muscle groups

Combination Approach: The most effective strategy combines both aerobic and resistance exercise

The Evidence for Exercise in NAFLD

A comprehensive meta-analysis gathering and analysing 24 studies suggested that exercise reduced intrahepatic triglycerides by 20-30%. In a randomised controlled trial, 220 obese patients with NAFLD were divided into three groups: no exercise (control), moderate exercise, and vigorous exercise. After 1-year intervention, both exercise groups showed decreased waist circumference, intrahepatic triglyceride content, blood pressure, and hepatic fat accumulation compared to controls.

Another systematic review and meta-analysis analyzing 54 articles described significant reductions in blood pressure, insulin resistance, and intrahepatic fat after exercise-training interventions, demonstrating exercise’s multifaceted benefits for metabolic health.

The Mechanisms: How Exercise Heals the Liver

Physical activity improves liver health through several pathways:

1. Enhanced Fat Metabolism

Exercise activates the AMPK (adenosine 5′-monophosphate-activated protein kinase) and PGC-1α (peroxisome-proliferator-activated-receptor-γ-coactivator-1α) signalling pathways, which increase hepatic β-oxidation (fat burning) and suppress lipogenesis (fat production).

Fascinating research on maternal exercise in obese dams showed that physical activity prevented western-style-diet-induced hepatic steatosis by increasing hepatic β-oxidation and suppressing lipogenesis through AMPK-PGC-1α pathway activation. Remarkably, the offspring also displayed increased AMPK-PGC1α activity and were protected against diet-induced fat accumulation and liver steatosis later in life.

2. Improved Insulin Sensitivity

Exercise enhances insulin sensitivity independently of weight loss, helping to address one of the core metabolic dysfunctions underlying NAFLD.

3. Reduced Inflammation

Physical activity decreases systemic inflammation and reduces inflammatory markers that drive NAFLD progression.

4. Improved Gut Microbiome

Exercise beneficially modulates gut microbiome composition, reducing dysbiosis and improving the gut-liver axis—a critical but often overlooked mechanism we’ll explore in detail below.

Making Exercise Sustainable

The challenge with exercise recommendations is adherence. The benefits of exercise are only established after relatively long periods of consistent activity, which causes many individuals to give up. To maximise success:

• Start gradually and build consistency before intensity
• Choose activities you enjoy
• Set realistic, incremental goals
• Track progress to maintain motivation
• Consider group classes or exercise partners for accountability

The Gut-Liver Axis: A Foundational Approach to Fatty Liver Treatment

One of the most exciting developments in NAFLD research over the past decade has been the recognition of the gut-liver axis—the bidirectional communication pathway between the intestine and liver. Understanding and optimising this connection may be one of the most important steps you can take to reverse fatty liver disease.

Understanding the Gut-Liver Connection

The liver and gut are anatomically connected through the portal vein, which carries blood directly from the intestines to the liver. This means that approximately 70% of the liver’s blood supply comes from the gut, carrying nutrients, bacterial products, and metabolic signals. When the gut is healthy, this is beneficial. When the gut is dysfunctional, it becomes a direct pathway for problems to reach the liver.

Research consistently shows that patients with NAFLD have distinctly different gut microbiome compositions compared to healthy individuals, characterized by:

• Decreased overall bacterial diversity
• Altered Firmicutes to Bacteroidetes ratio
• Reduced beneficial bacteria like Akkermansia muciniphila and Faecalibacterium prausnitzii
• Increased pathogenic bacterial strains
• Small intestinal bacterial overgrowth (SIBO)

Discover the reasons for your gut symptoms.

View our gut health tests

How Gut Dysfunction Drives Fatty Liver Disease

Multiple mechanisms connect gut dysbiosis to NAFLD:

1. Increased Intestinal Permeability (“Leaky Gut”)

Dysbiosis damages the intestinal barrier, allowing bacterial products like lipopolysaccharides (LPS) to leak into the bloodstream and reach the liver through portal circulation. LPS triggers immune activation through TLR4 receptors, promoting inflammation, hepatocyte damage, and fibrosis.

2. Altered Bacterial Metabolite Production

Your gut bacteria produce metabolites that profoundly affect liver metabolism:

• Short-Chain Fatty Acids (SCFAs): Beneficial bacteria produce butyrate, acetate, and propionate through fiber fermentation. These SCFAs have anti-inflammatory properties and maintain gut barrier integrity. Reduced SCFA production in NAFLD patients contributes to inflammation and gut permeability.
• Bile Acids: Gut bacteria modify primary bile acids into secondary bile acids, which activate receptors (FXR and TGR5) that regulate glucose and lipid metabolism. Dysbiosis disrupts this balance, contributing to metabolic dysfunction.
• Trimethylamine N-oxide (TMAO): Certain bacteria break down dietary choline into trimethylamine (TMA), which the liver converts to TMAO. Elevated TMAO levels are associated with increased cardiovascular risk and may contribute to liver damage.
• Endogenous Alcohol Production: Some bacterial strains can produce ethanol in the gut, potentially causing liver inflammation even without external alcohol consumption.

3. Enhanced Energy Harvest

An altered microbiome may increase energy extraction from food, contributing to weight gain and fat accumulation in the liver.

4. Chronic Inflammation

Dysbiosis promotes systemic low-grade inflammation through various mechanisms, including activation of TLR4-dependent pathways and production of pro-inflammatory cytokines.

Small Intestinal Bacterial Overgrowth (SIBO) and NAFLD

SIBO—excessive bacterial colonisation of the small intestine—has emerged as an important factor in fatty liver disease. Studies show varying results, but meta-analyses have found:

• SIBO prevalence in NAFLD patients can reach approximately 35%
• Odds ratios ranging from 1.5 to 3.82 for NAFLD among patients with SIBO
• Higher rates of intestinal permeability and bacterial translocation in NAFLD patients with SIBO

SIBO may contribute to liver dysfunction through:

• Nutrient Malabsorption: SIBO causes deficiencies in vitamin B12, iron, choline, and fats—nutrients essential for liver function. Choline deficiency, in particular, directly impairs fat metabolism in the liver.
• Increased Bacterial Translocation: Excessive small intestinal bacteria produce more LPS and inflammatory compounds that reach the liver.
• Metabolic Disturbances: SIBO is associated with insulin resistance and other metabolic abnormalities characteristic of NAFLD.

Could SIBO be contributing to your fatty liver? If you experience digestive symptoms like bloating, abdominal discomfort, diarrhea, or constipation alongside metabolic concerns, SIBO testing could provide crucial insights.

Our specialised SIBO breath tests can identify bacterial overgrowth that may be undermining your liver health and metabolic function. Accurate diagnosis is the first step toward targeted treatment.

Restoring Gut Health: A Multi-Pronged Approach

Given the critical role of the gut-liver axis in NAFLD, restoring gut health should be a foundational component of any fatty liver treatment plan.

1. Comprehensive Gut Microbiome Assessment

Understanding your unique gut microbiome composition is essential for personalized intervention. Advanced microbiome testing can reveal:

• Bacterial diversity and balance
• Presence of pathogenic strains
• Beneficial bacteria levels
• Functional capacity of your microbiome

Ready to understand what’s happening in your gut? Our comprehensive microbiome testing provides detailed insights into your bacterial composition, helping identify imbalances that may be contributing to fatty liver disease.

2. Targeted Probiotic Therapy

Recommended Product: VSL#3

Probiotics—live beneficial bacteria—have emerged as a promising therapeutic approach for NAFLD. The ability of probiotics to reverse gut dysbiosis has generated increasing interest as an alternative or complementary treatment option.

The Evidence for Probiotics in NAFLD:

All major studies reviewing probiotic use in NAFLD have found beneficial effects, including:

• Improvement in liver enzymes (ALT, AST)
• Reduction in hepatic inflammation
• Decreased hepatic steatosis
• Improvement in hepatic fibrosis markers
• Reduction in oxidative stress and inflammatory cytokines
• Improved insulin sensitivity

A systematic review and meta-analysis of randomised controlled trials found that probiotic and synbiotic use was associated with:

• Significant improvement in liver-specific markers of hepatic inflammation
• Reduction in liver stiffness measurements
• Improvement in hepatic steatosis as graded by ultrasound

Mechanisms of Action:

Probiotics improve NAFLD through multiple pathways:

• Restoring gut microbiome balance and diversity
• Strengthening the intestinal barrier and reducing permeability
• Decreasing bacterial translocation and endotoxemia
• Reducing oxidative stress and inflammatory liver damage
• Modulating bile acid metabolism
• Improving insulin sensitivity
• Reducing fat accumulation in the liver

Most Effective Probiotic Strains:

Research suggests certain strains are particularly beneficial for NAFLD:

• Lactobacillus species: L. acidophilus, L. bulgaricus, L. rhamnosus, L. plantarum
• Bifidobacterium species: B. longum, B. bifidum, B. breve, B. lactis
• Other beneficial strains: Faecalibacterium prausnitzii (a key butyrate producer)

Multi-strain formulations often show the best results. One study using VSL#3 (a multi-strain probiotic) showed significant improvements in liver enzymes, TNF-α, and oxidative stress markers in NAFLD patients after 2-3 months.

Support your gut-liver axis with targeted probiotic therapy. Our scientifically-formulated probiotic supplements contain multiple strains shown in research to benefit liver health, reduce inflammation, and support metabolic function.

3. Prebiotic Support

Prebiotics—dietary fibers that nourish beneficial bacteria—work synergistically with probiotics. Prebiotic fibers include:

• Inulin
• Fructo-oligosaccharides (FOS)
• Galacto-oligosaccharides (GOS)
• Resistant starch

Studies show that synbiotics (combined probiotics and prebiotics) may be even more effective than probiotics alone. One randomized controlled trial demonstrated that synbiotic supplementation significantly decreased liver enzymes, improved insulin resistance, reduced steatosis, and improved NASH activity index in patients with NAFLD.

Our prebiotic supplements provide the specialised fibers your beneficial bacteria need to thrive, supporting a healthy gut-liver axis and optimal metabolic function.

4. Address SIBO If Present

If SIBO is identified, targeted treatment is essential. Treatment options include:

• Antibiotic therapy (rifaximin is gut-selective and shows promise for NAFLD)
• Herbal antimicrobials
• Dietary modifications (low FODMAP diet during treatment)
• Prokinetic agents to improve gut motility

Research shows that rifaximin, a gut-selective antibiotic, improves intestinal permeability, decreases portal endotoxin, reduces lobular inflammation, hepatic steatosis, and fibrogenesis in NASH models. Clinical trials demonstrate that rifaximin reduces insulin resistance and inflammation in NAFLD patients and is safe and effective.

5. Gut-Healing Nutrients

Certain nutrients specifically support intestinal barrier integrity and healing:

• L-glutamine: Primary fuel for intestinal cells
• Zinc: Essential for tight junction function
• Vitamin D: Regulates intestinal immunity and barrier function
• Omega-3 fatty acids: Reduce intestinal inflammation
• Curcumin: Supports gut barrier integrity and has anti-inflammatory properties

Our comprehensive gut health supplements combine these key nutrients to support intestinal healing, reduce permeability, and optimise the gut-liver connection.

Specific Dietary Strategies for Fatty Liver

Beyond adopting a Mediterranean-style diet, several specific dietary modifications can accelerate fatty liver improvement:

Foods to Emphasise

1. Omega-3 Rich Foods

Fatty fish (salmon, mackerel, sardines), walnuts, flaxseeds, and chia seeds provide anti-inflammatory omega-3 fatty acids. Aim for at least 2-3 servings of fatty fish per week, or consider supplementation with high-quality fish oil providing >2g combined EPA and DHA daily.

2. Fiber-Rich Foods

Vegetables, fruits, legumes, and whole grains provide fiber that:

• Feeds beneficial gut bacteria
• Improves insulin sensitivity
• Supports healthy weight loss
• Reduces cholesterol absorption

Aim for 25-35g of fiber daily from whole food sources.

3. Coffee

Emerging evidence suggests coffee consumption may protect against NAFLD progression. Studies show that coffee drinkers have lower rates of liver fibrosis and cirrhosis. The protective effects appear related to coffee’s antioxidant and anti-inflammatory compounds. Aim for 2-3 cups daily if tolerated.

4. Cruciferous Vegetables

Broccoli, Brussels sprouts, cauliflower, and kale contain compounds that support liver detoxification and may reduce fat accumulation.

5. Fermented Foods

Yogurt, kefir, sauerkraut, kimchi, and other fermented foods provide natural probiotics and support gut health.

Foods to Limit or Avoid

1. Added Sugars and Fructose

Limit all forms of added sugars, with special attention to:

• Sweetened beverages (soda, fruit juices, sports drinks)
• High-fructose corn syrup
• Processed sweets and desserts

Fructose is particularly problematic as it’s metabolised primarily in the liver and directly promotes fat accumulation, inflammation, and insulin resistance.

2. Refined Carbohydrates

White bread, white rice, pasta made from refined flour, and processed snacks cause rapid blood sugar spikes and promote fat storage in the liver.

3. Saturated and Trans Fats

Minimize intake of:

• Red meat and processed meats
• Full-fat dairy (unless fermented)
• Trans fats (partially hydrogenated oils, fried foods, commercial baked goods)

4. Alcohol

Even moderate alcohol consumption can accelerate NAFLD progression. Complete abstinence is generally recommended for anyone with fatty liver disease.

5. Processed Foods

Minimise packaged and processed foods, which typically contain excess sodium, unhealthy fats, added sugars, and additives that promote inflammation and dysbiosis.

Biologically Active Compounds and Supplements for Fatty Liver

While lifestyle modification remains the foundation of treatment, certain supplements and bioactive compounds show promise as complementary therapies for NAFLD.

Evidence-Based Supplements

1. Vitamin E

Vitamin E is an effective antioxidant that ameliorates oxidative stress, inflammation, and fibrosis in NAFLD. Studies show that vitamin E (800 IU daily) reduces liver steatosis, hepatocyte apoptosis, and inflammation in adults with NAFLD and is generally well-tolerated.

Vitamin E activates the Nrf2/carboxylesterase 1 signaling pathway, reducing liver steatosis and lipid accumulation. It’s advised for managing NAFLD in guidance from major medical organizations.

Caution: Long-term high-dose vitamin E supplementation has been associated with increased risk of certain conditions, so it should be used under medical supervision.

2. Vitamin D

Low levels of vitamin D are associated with increased risk and severity of NAFLD. Vitamin D regulates intestinal function, reduces oxidative stress and lipid accumulation, and improves insulin sensitivity.

Research demonstrates that vitamin D supplementation enhances liver function and decreases lipid accumulation, insulin resistance, blood fat, and oxidative stress in patients with NAFLD. Mechanisms include anti-inflammation, anti-fibrosis effects, and metabolic regulation.

3. Berberine

Berberine, an alkaloid extracted from various plants, shows multiple benefits for NAFLD:

• Activates AMPK signaling pathway
• Reduces stearoyl-CoA desaturase-1 (a rate-limiting enzyme in fatty acid synthesis)
• Blocks NLRP3 inflammasome assembly (anti-inflammatory effect)
• Modulates macrophage infiltration and polarization
• Activates Nrf2 signaling (antioxidant protection)
• Modulates gut microbiota composition

Meta-analyses of randomizsed clinical trials show that berberine is beneficial for liver function and blood lipid improvement in patients with NAFLD.

4. Silymarin (Milk Thistle)

Silymarin, obtained from milk thistle seeds, has been used for liver diseases for centuries. Studies show it:

• Reduces inflammation and apoptosis
• Normalises glycemia, lipid profile, and liver function
• Improves liver fibrosis
• Enhances FXR transcriptional activity
• Inhibits NF-κB signalling
• Ameliorates insulin resistance

Clinical trials demonstrate that silymarin reduces liver fibrosis in adult patients with biopsy-proven NASH and is safe and well-tolerated. Combination with vitamin C, vitamin E, coenzyme Q10, and selenomethionine may enhance effectiveness.

5. Curcumin

Curcumin, extracted from turmeric, has potent antioxidant and anti-inflammatory activities. Randomised controlled trials reveal that curcumin:

• Reduces blood fat and lipid accumulation
• Ameliorates obesity and liver function
• Improves insulin metabolism
• Reduces blood glucose, oxidative stress, and inflammation

Network analysis suggests curcumin may treat NAFLD through 14 target genes, including key metabolic and inflammatory pathways.

6. Resveratrol

Resveratrol, found in grapes, peanuts, and berries, ameliorates metabolic syndrome and NAFLD through:

• Reduction of hepatic lipid accumulation
• Regulation of glycemic and lipid metabolism via sirtuin 1/AMPK/NF-κB pathways
• Reduction of HFD-induced methylation of the Nrf2 promoter
• Decreased expression of lipogenesis-related genes
• Reduced reactive oxygen species production

Studies show that resveratrol supplementation improves blood fat, hepatic steatosis, hepatic apoptosis, liver function, and insulin sensitivity in NAFLD patients.

7. Omega-3 Fatty Acids

High-quality fish oil supplements providing EPA and DHA have shown benefits in multiple studies:

• Reduced liver fat
• Improved insulin sensitivity
• Decreased inflammatory markers
• Better lipid profiles

Supplementation with n-3 PUFA (>2 g/day) appears to be an effective way to control metabolic syndrome and NAFLD.

Advanced and Emerging Therapies

While lifestyle modification remains the first-line treatment, several advanced therapies show promise for patients with more severe disease or those who cannot achieve sufficient weight loss through lifestyle alone.

Medications Under Investigation

1. GLP-1 Receptor Agonists

Glucagon-like peptide-1 (GLP-1) analogues have shown promising results:

• Liraglutide: Reduces inflammation and fat accumulation, normalises glycemic parameters and gut microbiota composition. Studies show NAFLD was attenuated in 39% of subjects, though gastrointestinal side effects occurred in some patients.
• Semaglutide: Treatment reduces NASH and positively impacts NAFLD through decreasing lipid accumulation and inflammation, and regulating blood sugar and liver function. Placebo-controlled trials show significant improvements.
• Dulaglutide: Reduces lipid accumulation and normalises liver function in NAFLD patients in randomised controlled trials.

2. PPAR Agonists

Peroxisome proliferator-activated receptors (PPARs) regulate glucose and lipid metabolism:

• Pioglitazone: Improves liver function, insulin sensitivity, and reduces inflammation in NAFLD, though it causes weight gain.
• Saroglitazar: A dual PPARα/γ agonist that ameliorates insulin sensitivity and lipid parameters. Studies suggest it may be more effective than other PPAR agonists.

3. FXR Agonists

Farnesoid X receptor (FXR) regulates bile acid homeostasis and has shown promise in NAFLD treatment, though pruritus and elevated blood lipids are common side effects.

Bariatric Surgery

For patients with severe obesity and NAFLD, bariatric surgery can be highly effective:

• Laparoscopic Sleeve Gastrectomy: Markedly ameliorates liver histological features, oxidative stress, and inflammation
• Roux-en-Y Gastric Bypass: Ameliorates hepatic steatosis through multiple pathways, including mTOR/AKT2 signalling
• Biliopancreatic Diversion: Reverses whole-body insulin resistance and reduces inflammation

Studies show that bariatric surgery not only achieves long-term weight loss but also attenuates hypertension, type 2 diabetes, insulin resistance, and fibrosis. However, costs, patient acceptability, and side effects (including nutrient deficiencies, vomiting, diarrhea, and infection) limit implementation.

Creating Your Personalised Fatty Liver Reversal Plan

Successfully reversing fatty liver disease requires a comprehensive, personalised approach. Here’s how to create your plan:

Step 1: Get Comprehensive Testing

Before starting treatment, establish your baseline with:

• Liver function tests (ALT, AST, GGT, alkaline phosphatase)
• Metabolic panel (fasting glucose, HbA1c, lipid panel, insulin levels)
• Liver imaging (ultrasound, FibroScan, or MRI-PDFF)
• Non-invasive fibrosis assessment (FIB-4, APRI score, or elastography)
• Gut microbiome testing to identify dysbiosis
• SIBO breath testing if digestive symptoms are present

Start with understanding your unique biology. Our comprehensive microbiome and SIBO testing provide the insights you need to create a truly personalised treatment plan that addresses root causes, not just symptoms.

Step 2: Set Realistic Weight Loss Goals

If you need to lose weight, aim for:

• Initial goal: 7-10% of body weight
• Optimal goal: ≥10% of body weight
• Rate: 0.5-1 kg (1-2 pounds) per week for sustainable loss

Remember that even modest weight loss (3-5%) provides liver benefits, so celebrate incremental progress.

Step 3: Implement Dietary Changes

• Adopt a Mediterranean-style eating pattern
• Eliminate added sugars and refined carbohydrates
• Increase fiber intake to 25-35g daily
• Include omega-3 rich foods regularly
• Add fermented foods to support gut health
• Stay well-hydrated

Step 4: Establish an Exercise Routine

• Start with 30 minutes of moderate activity 5 days per week
• Gradually increase to 150 minutes per week
• Add resistance training 2-3 times per week
• Choose activities you enjoy for long-term adherence

Step 5: Optimize Your Gut Health

• Test: Understand your gut microbiome composition and check for SIBO
• Restore: Use targeted probiotics and prebiotics
• Repair: Support intestinal barrier function with gut-healing nutrients
• Address: Treat SIBO if present
• Maintain: Continue probiotic and prebiotic support long-term

Ready to heal your gut-liver axis? Our comprehensive gut health protocol includes targeted testing, therapeutic-grade probiotics, prebiotics, and gut-healing nutrients—everything you need to restore balance and support liver health.

Step 6: Consider Targeted Supplementation

Work with your healthcare provider to determine if supplementation with:

• Vitamin E
• Vitamin D
• Omega-3 fatty acids
• Berberine
• Silymarin
• Curcumin

…would be appropriate for your situation.

Our liver support supplements combine research-backed nutrients in therapeutic doses to complement your lifestyle changes and accelerate liver healing.

Step 7: Monitor Progress

Regular follow-up is essential:

• Repeat liver enzymes every 3-6 months
• Reassess liver imaging at 6-12 months
• Track weight, waist circumference, and metabolic markers
• Adjust your plan based on results

Step 8: Address Related Conditions

Optimise management of:

• Type 2 diabetes
• Hypertension
• Dyslipidemia
• Sleep apnea
• Other metabolic syndrome components

The Timeline: What to Expect

Understanding realistic timelines helps maintain motivation:

Weeks 1-4: Initial dietary and lifestyle changes. You may notice improved energy, reduced bloating, and early weight loss.

Months 1-3: Liver enzymes often begin to improve. Weight loss becomes more apparent. Gut symptoms may improve with probiotic therapy.

Months 3-6: Significant improvements in liver enzymes, metabolic markers, and liver fat content on imaging. Many patients achieve 5-7% weight loss.

Months 6-12: Further reductions in liver fat, inflammation markers, and potential reversal of early fibrosis. Optimal results typically achieved with ≥10% weight loss.

Year 1+: Continued improvement with sustained lifestyle changes. Focus shifts to maintenance and preventing recurrence.

Remember: This is a marathon, not a sprint. Sustainable changes that you can maintain for years are far more valuable than extreme measures that can’t be sustained.

The Role of Stress Management and Sleep

Often overlooked but critically important, stress management and quality sleep significantly impact both fatty liver disease and gut health.

Stress and the Gut-Liver Axis

Chronic stress:

• Alters gut microbiome composition
• Increases intestinal permeability
• Promotes inflammation
• Worsens insulin resistance
• Increases cortisol, which promotes abdominal fat accumulation

Stress reduction strategies:

• Mindfulness meditation (even 10 minutes daily helps)
• Deep breathing exercises
• Yoga or tai chi
• Time in nature
• Adequate social connection
• Professional counseling if needed

Sleep and Metabolic Health

Poor sleep:

• Worsens insulin resistance
• Increases appetite and cravings
• Disrupts hormonal balance
• Promotes weight gain
• Negatively affects gut microbiome

Sleep optimisation strategies:

• Aim for 7-9 hours nightly
• Maintain consistent sleep/wake times
• Create a dark, cool sleeping environment
• Limit screen time before bed
• Address sleep apnea if present

Monitoring for Complications and When to Seek Additional Help

While lifestyle modifications are highly effective for most people with NAFLD, it’s important to know when additional medical intervention may be needed.

Warning Signs Requiring Medical Attention

Contact your healthcare provider if you experience:

• Persistent or worsening fatigue
• Unexplained weight loss
• Abdominal swelling
• Yellowing of skin or eyes (jaundice)
• Easy bruising or bleeding
• Confusion or difficulty concentrating
• Dark urine or pale stools

When to Consider Advanced Therapies

Discuss additional treatment options if:

• Lifestyle modifications don’t improve liver enzymes after 6 months
• Imaging shows worsening steatosis or developing fibrosis
• You have NASH with significant fibrosis
• You’re unable to achieve necessary weight loss through lifestyle alone
• You have severe metabolic syndrome that’s difficult to control

Discover the reasons for your gut symptoms.

View our gut health tests

The Bottom Line: A Comprehensive Approach Works Best

Reversing fatty liver disease is absolutely achievable for most people, especially when caught early. The most effective approach combines:

1. Weight loss through sustainable lifestyle changes (goal: 7-10% or more)
2. Mediterranean-style diet emphasising whole foods, healthy fats, and abundant vegetables
3. Regular physical activity combining aerobic and resistance exercise
4. Gut health optimisation through microbiome testing, probiotics, prebiotics, and SIBO treatment if needed
5. Targeted supplementation with evidence-based nutrients
6. Stress management and quality sleep
7. Regular monitoring of progress and adjustment of approach as needed

The gut-liver axis represents one of the most important and often overlooked aspects of fatty liver treatment. By addressing gut dysbiosis, reducing intestinal permeability, optimising bacterial metabolite production, and treating SIBO when present, you create the foundation for successful liver healing.

Your journey to liver health starts with understanding your body. Comprehensive testing of your gut microbiome and screening for SIBO provides crucial information that allows you to create a truly personalised treatment plan. Combined with targeted probiotic therapy, prebiotic support, and gut-healing nutrients, you can address the root causes of fatty liver disease while implementing proven dietary and lifestyle changes.

The time to act is now. The earlier you intervene, the better your outcomes. But even if you’ve had fatty liver disease for years, meaningful improvement is still possible with the right approach. Your liver has remarkable regenerative capacity—give it the support it needs through comprehensive lifestyle changes, gut health optimisation, and targeted interventions.

Ready to take the first step? Start with comprehensive gut microbiome and SIBO testing to understand your unique situation. Then support your gut-liver axis with our therapeutic-grade probiotics, prebiotics, and liver support supplements—all formulated based on the latest research to give you the best chance of success.

Your liver health is worth the investment. Let’s work together to reverse fatty liver disease and restore your metabolic health from the inside out.

---

References

1. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388-1402. https://pubmed.ncbi.nlm.nih.gov/27062661/
2. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367-378.e5. https://pubmed.ncbi.nlm.nih.gov/25865049/
3. Romero-Gomez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017;67(4):829-846. https://pubmed.ncbi.nlm.nih.gov/28545937/
4. Hashida R, Kawaguchi T, Bekki M, et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review. J Hepatol. 2017;66(1):142-152. https://pubmed.ncbi.nlm.nih.gov/27639843/
5. Zhang HJ, Pan LL, Ma ZM, et al. Long-term effect of exercise on improving fatty liver and cardiovascular risk factors in obese adults: A 1-year follow-up study. Diabetes Obes Metab. 2017;19(2):284-289. https://pubmed.ncbi.nlm.nih.gov/27753234/
6. Wong VW, Wong GL, Chan RS, et al. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease. J Hepatol. 2018;69(6):1349-1356. https://pubmed.ncbi.nlm.nih.gov/30142427/
7. Kasper P, Breuer S, Hoffmann T, et al. Maternal exercise mediates hepatic metabolic programming via activation of AMPK-PGC1α axis in the offspring of obese mothers. Cells. 2021;10(6):1247. https://pubmed.ncbi.nlm.nih.gov/34063746/
8. Leung C, Rivera L, Furness JB, Angus PW. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol. 2016;13(7):412-425. https://www.nature.com/articles/nrgastro.2016.85
9. Aron-Wisnewsky J, Vigliotti C, Witjes J, et al. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat Rev Gastroenterol Hepatol. 2020;17(5):279-297. https://pubmed.ncbi.nlm.nih.gov/32152478/
10. Gudan A, Jamioł-Milc D, Hawryłkowicz V, Skonieczna-Żydecka K, Stachowska E. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis—A Systematic Review, Meta-Analysis and Meta-Regression. Nutrients. 2022;14(24):5261. https://www.mdpi.com/2072-6643/14/24/5261
11. Wijarnpreecha K, Lou S, Watthanasuntorn K, et al. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2020;32(5):601-608. https://pubmed.ncbi.nlm.nih.gov/31567712/
12. Ma YY, Li L, Yu CH, Shen Z, Chen LH, Li YM. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol. 2013;19(40):6911-6918. https://pubmed.ncbi.nlm.nih.gov/24187469/
13. Xue L, He J, Gao N, et al. Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia. Sci Rep. 2017;7:45176. https://pubmed.ncbi.nlm.nih.gov/28338077/
14. Alisi A, Bedogni G, Baviera G, et al. Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2014;39(11):1276-1285. https://pubmed.ncbi.nlm.nih.gov/24738701/
15. Eslamparast T, Poustchi H, Zamani F, et al. Synbiotic supplementation in nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled pilot study. Am J Clin Nutr. 2014;99(3):535-542. https://pubmed.ncbi.nlm.nih.gov/24401715/
16. Abdel-Razik A, Mousa N, Shabana W, et al. Rifaximin in nonalcoholic fatty liver disease: Hit multiple targets with a single shot. Eur J Gastroenterol Hepatol. 2018;30(10):1237-1246. https://pubmed.ncbi.nlm.nih.gov/30001296/
17. Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362(18):1675-1685. https://pubmed.ncbi.nlm.nih.gov/20427778/
18. He W, Xu Y, Ren X, et al. Vitamin E ameliorates lipid metabolism in mice with nonalcoholic fatty liver disease via Nrf2/CES1 signaling pathway. Dig Dis Sci. 2019;64(11):3182-3191. https://pubmed.ncbi.nlm.nih.gov/31090009/
19. Sharifi N, Amani R, Hajiani E, Cheraghian B. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine. 2014;47(1):70-80. https://pubmed.ncbi.nlm.nih.gov/24968737/
20. Wei X, Wang C, Hao S, Song H, Yang L. The therapeutic effect of berberine in the treatment of nonalcoholic fatty liver disease: A meta-analysis. Evid Based Complement Alternat Med. 2016;2016:3593951. https://pubmed.ncbi.nlm.nih.gov/27974907/
21. Wah Kheong C, Nik Mustapha NR, Mahadeva S. A Randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2017;15(12):1940-1949.e8. https://pubmed.ncbi.nlm.nih.gov/28842305/
22. Panahi Y, Kianpour P, Mohtashami R, et al. Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: A randomized controlled trial. Drug Res (Stuttg). 2017;67(4):244-251. https://pubmed.ncbi.nlm.nih.gov/27997969/
23. Faghihzadeh F, Adibi P, Hekmatdoost A. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: A randomised, double-blind, placebo-controlled study. Br J Nutr. 2015;114(5):796-803. https://pubmed.ncbi.nlm.nih.gov/26218845/
24. Armstrong MJ, Gaunt P, Aithal GP, et al. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet. 2016;387(10019):679-690. https://pubmed.ncbi.nlm.nih.gov/26608256/
25. Newsome PN, Buchholtz K, Cusi K, et al. A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N Engl J Med. 2021;384(12):1113-1124. https://pubmed.ncbi.nlm.nih.gov/33185364/